Sigmak Lifesciences partners with pharmaceutical manufacturers, importers, and distributors in Nigeria to supply WHO-GMP sourced injectable formulations, active pharmaceutical ingredients, nutraceuticals, and specialty chemical intermediates. Nigeria is the largest pharmaceutical market in West Africa, with product registration and import oversight managed by NAFDAC (National Agency for Food and Drug Administration and Control).
The injectable portfolio covers anti-malarials, antibiotics, anti-TB agents, anti-infectives, cardiovascular formulations, analgesics, vitamins, and critical care products in ampoule, vial, and dry powder formats. Documentation packages including COA, COPP, and stability data are structured to support NAFDAC registration and import dossier requirements.
Sigmak provides responsive supply and documentation support for institutional procurement, hospital tenders, and branded generic distribution across Nigeria's major commercial and government healthcare channels.